首页 > 最新文献

Medicines (Basel, Switzerland)最新文献

英文 中文
Deep Vein Thrombosis of the Left Lower Limb in a Sudanese Child with Sickle Cell Disease. 苏丹镰状细胞病患儿左下肢深静脉血栓形成
Pub Date : 2022-10-22 DOI: 10.3390/medicines9110052
Alam Eldin Musa Mustafa, Niemat Mohammed Tahir, Nur Allah Elnaji Ahmed Mohamed, Adil Abdullah Mohammed, Sara Ismail Mohammed

This is a case of an eleven-year-old female Sudanese child, a known Sickle Cell Anemia (SCA) patient, who presented with fever, as well as left thigh and leg swelling that was associated with pain and warmness, which was diagnosed as Deep Vein Thrombosis (DVT) of her left lower limb. She had a previous history of admissions to the emergency room, during which she once received blood. The patient was managed by carrying out a basic routine initial laboratory investigation. A Doppler ultrasound scan showed features consistent with DVT. Based on the clinical findings and investigation results, management began by providing the patient with intravenous fluid, analgesia, packed Red Blood Cells (RBCs), intravenous antibiotics, and low-molecular-weight heparin. Further consultations showed that there was no need for vascular surgery or surgical intervention. This case highlights the need for more studies on DVT and Venous Thromboembolism (VTE) complications in children with SCA, so as to develop strategies for diagnosis and management in order to reduce the risk of life-threatening complications of VTE in patients with Sickle Cell Disease SCD.

这是一个11岁苏丹女儿童的病例,已知的镰状细胞性贫血(SCA)患者,表现为发烧,以及左大腿和腿部肿胀,伴有疼痛和发热,诊断为左下肢深静脉血栓形成(DVT)。她以前曾被送往急诊室,在此期间她曾接受过输血。对患者进行了基本的常规初步实验室检查。多普勒超声扫描显示深静脉血栓的特征。根据临床表现和调查结果,治疗开始为患者提供静脉输液、镇痛、红细胞(rbc)、静脉注射抗生素和低分子肝素。进一步的咨询表明不需要血管手术或手术干预。本病例提示需要对SCA患儿DVT及静脉血栓栓塞(Venous Thromboembolism, VTE)并发症进行更多研究,以制定诊断和治疗策略,降低镰状细胞病SCD患者发生危及生命的VTE并发症的风险。
{"title":"Deep Vein Thrombosis of the Left Lower Limb in a Sudanese Child with Sickle Cell Disease.","authors":"Alam Eldin Musa Mustafa,&nbsp;Niemat Mohammed Tahir,&nbsp;Nur Allah Elnaji Ahmed Mohamed,&nbsp;Adil Abdullah Mohammed,&nbsp;Sara Ismail Mohammed","doi":"10.3390/medicines9110052","DOIUrl":"https://doi.org/10.3390/medicines9110052","url":null,"abstract":"<p><p>This is a case of an eleven-year-old female Sudanese child, a known Sickle Cell Anemia (SCA) patient, who presented with fever, as well as left thigh and leg swelling that was associated with pain and warmness, which was diagnosed as Deep Vein Thrombosis (DVT) of her left lower limb. She had a previous history of admissions to the emergency room, during which she once received blood. The patient was managed by carrying out a basic routine initial laboratory investigation. A Doppler ultrasound scan showed features consistent with DVT. Based on the clinical findings and investigation results, management began by providing the patient with intravenous fluid, analgesia, packed Red Blood Cells (RBCs), intravenous antibiotics, and low-molecular-weight heparin. Further consultations showed that there was no need for vascular surgery or surgical intervention. This case highlights the need for more studies on DVT and Venous Thromboembolism (VTE) complications in children with SCA, so as to develop strategies for diagnosis and management in order to reduce the risk of life-threatening complications of VTE in patients with Sickle Cell Disease SCD.</p>","PeriodicalId":74162,"journal":{"name":"Medicines (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697196/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40690797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physical Activity in the Elderly and Frailty Syndrome: A Retrospective Study in Primary Care 老年人体力活动与虚弱综合征:一项初级保健回顾性研究
Pub Date : 2022-10-01 DOI: 10.3390/medicines9100051
A. Zulfiqar, H. Habchi, Perla Habchi, I. Dembélé, E. Andrès
Objectives: Physical activity carries numerous therapeutic benefits, and it is more effective when applied before the onset of symptoms. The objective of this study is to compare the correlation of the evaluation of physical activity carried out using the Ricci and Gagnon test and the frailty profile measured by the mSEGA scale in a population of patients consulting in general medicine. Methods: We conducted a retrospective study within a general practitioner clinic in Chaumont and Bologne (Haute-Marne department) during a 3-month period. Patients aged 65 years and up were screened for frailty using the modified SEGA (mSEGA) assessment, and physical activity was measured using the Ricci–Gagnon questionnaire. Results: A total of 44 patients were selected, with a slightly female predominance (59.1%). Of these, 21 patients reported having worked in manual labor. Seven patients were found to be frail using the SEGAm assessment, while 10 (22.73%) patients had an inactive profile according the Ricci–Gagnon score. Malnutrition was detected in six patients (13.64%) using the MNA survey. Frailty as defined by the mSEGA scale had no statistical correlation (p = 0.68) with the Ricci–Gagnon score. A Ricci–Gagnon inactive profile showed statistical correlations with fall indicators (unipedal balance test, p = 0.014) and malnutrition scores using the MNA (p = 0.0057) as well as with the Charlson Comorbidity Index (p = 0.027). Conclusion: A systematic survey of the elderly by a general practitioner implementing a regular and suitable physical activity regimen would allow a better screening of frailty, minimizing its complications.
目的:体育活动具有许多治疗益处,在症状出现之前进行体育活动更有效。本研究的目的是比较使用Ricci和Gagnon测试进行的体力活动评估与使用mSEGA量表在普通医学咨询患者群体中测量的虚弱状况之间的相关性。方法:我们在Chaumont和Bologne(上马恩省)的一家全科医生诊所进行了一项为期3个月的回顾性研究。使用改良SEGA(mSEGA)评估对65岁及以上的患者进行虚弱筛查,并使用Ricci–Gagnon问卷测量体力活动。结果:共选择44名患者,其中女性略占优势(59.1%)。其中21名患者报告曾从事体力劳动。根据SEGAm评估,有7名患者身体虚弱,而根据Ricci–Gagnon评分,有10名患者(22.73%)处于不活动状态。MNA调查发现6名患者(13.64%)营养不良。mSEGA量表定义的虚弱与Ricci–Gagnon评分没有统计学相关性(p=0.68)。Ricci–Gagnon的不活跃状况与跌倒指标(单足平衡测试,p=0.014)、MNA营养不良评分(p=0.0057)以及Charlson共病指数(p=0.027)具有统计学相关性虚弱的症状,最大限度地减少并发症。
{"title":"Physical Activity in the Elderly and Frailty Syndrome: A Retrospective Study in Primary Care","authors":"A. Zulfiqar, H. Habchi, Perla Habchi, I. Dembélé, E. Andrès","doi":"10.3390/medicines9100051","DOIUrl":"https://doi.org/10.3390/medicines9100051","url":null,"abstract":"Objectives: Physical activity carries numerous therapeutic benefits, and it is more effective when applied before the onset of symptoms. The objective of this study is to compare the correlation of the evaluation of physical activity carried out using the Ricci and Gagnon test and the frailty profile measured by the mSEGA scale in a population of patients consulting in general medicine. Methods: We conducted a retrospective study within a general practitioner clinic in Chaumont and Bologne (Haute-Marne department) during a 3-month period. Patients aged 65 years and up were screened for frailty using the modified SEGA (mSEGA) assessment, and physical activity was measured using the Ricci–Gagnon questionnaire. Results: A total of 44 patients were selected, with a slightly female predominance (59.1%). Of these, 21 patients reported having worked in manual labor. Seven patients were found to be frail using the SEGAm assessment, while 10 (22.73%) patients had an inactive profile according the Ricci–Gagnon score. Malnutrition was detected in six patients (13.64%) using the MNA survey. Frailty as defined by the mSEGA scale had no statistical correlation (p = 0.68) with the Ricci–Gagnon score. A Ricci–Gagnon inactive profile showed statistical correlations with fall indicators (unipedal balance test, p = 0.014) and malnutrition scores using the MNA (p = 0.0057) as well as with the Charlson Comorbidity Index (p = 0.027). Conclusion: A systematic survey of the elderly by a general practitioner implementing a regular and suitable physical activity regimen would allow a better screening of frailty, minimizing its complications.","PeriodicalId":74162,"journal":{"name":"Medicines (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47663212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Management of Salter–Harris Type 1 Fracture Complicated with Osteomyelitis in a Sickle Cell Disease Patient: A Case Report and Review of Literature 镰状细胞病患者Salter-Harris 1型骨折合并骨髓炎的治疗:1例报告及文献复习
Pub Date : 2022-09-22 DOI: 10.3390/medicines9100050
N. Opara, E. C. Osuala, U. I. Nwagbara
Salter–Harris fractures may occur due to a single injury or repetitive stress fractures on the extremities. Type I to III fractures are managed medically, while types IV and V, which are rare, are treated surgically. In the pediatric population, Salter–Harris I fractures of the distal tibia are commonly seen, and management of such fractures are well established in the literature. Despite the availability of a wide range of treatment for such fractures, osteonecrosis or avascular necrosis of the proximal femur can subsequently develop. Avascular necrosis is cell death secondary to metabolic disturbances, trauma, adverse effects of certain medications, or sickle cell disease. Avascular necrosis commonly affects the talus, humerus, or tibia in addition to the femoral head. Radiographic images are essential for prompt diagnosis and to minimize negative health outcomes in these patients. However, Salter–Harris I fracture in sickle cell patients can be very challenging due to these patients’ vulnerability to bone infections and sickle cell crisis. In this case report, our patient with a history of sickle cell disease and with a diagnosis of Salter–Harris I fracture was treated with surgical intervention as type V, which is discussed in this article, and responded well to treatment. Thus, this case suggests a new approach to managing Salter–Harris I fractures complicated with osteomyelitis in sickle cell patients.
Salter–Harris骨折可能是由于四肢的单一损伤或重复应力性骨折引起的。I型至III型骨折是通过医学治疗的,而IV型和V型骨折是罕见的,通过手术治疗。在儿科人群中,胫骨远端Salter–Harris I型骨折很常见,文献中对此类骨折的处理也很明确。尽管这种骨折有广泛的治疗方法,但股骨近端的骨坏死或缺血性坏死随后可能发展。缺血性坏死是指继发于代谢紊乱、创伤、某些药物的不良反应或镰状细胞病的细胞死亡。缺血性坏死通常影响距骨、肱骨或胫骨以及股骨头。射线图像对于这些患者的及时诊断和最大限度地减少负面健康结果至关重要。然而,镰状细胞病患者的Salter–Harris I骨折可能非常具有挑战性,因为这些患者容易受到骨骼感染和镰状细胞危象的影响。在本病例报告中,我们的患者有镰状细胞病病史,诊断为Salter–Harris I型骨折,采用本文讨论的V型手术干预治疗,治疗效果良好。因此,该病例为治疗镰状细胞病患者并发骨髓炎的Salter–Harris I骨折提供了一种新的方法。
{"title":"Management of Salter–Harris Type 1 Fracture Complicated with Osteomyelitis in a Sickle Cell Disease Patient: A Case Report and Review of Literature","authors":"N. Opara, E. C. Osuala, U. I. Nwagbara","doi":"10.3390/medicines9100050","DOIUrl":"https://doi.org/10.3390/medicines9100050","url":null,"abstract":"Salter–Harris fractures may occur due to a single injury or repetitive stress fractures on the extremities. Type I to III fractures are managed medically, while types IV and V, which are rare, are treated surgically. In the pediatric population, Salter–Harris I fractures of the distal tibia are commonly seen, and management of such fractures are well established in the literature. Despite the availability of a wide range of treatment for such fractures, osteonecrosis or avascular necrosis of the proximal femur can subsequently develop. Avascular necrosis is cell death secondary to metabolic disturbances, trauma, adverse effects of certain medications, or sickle cell disease. Avascular necrosis commonly affects the talus, humerus, or tibia in addition to the femoral head. Radiographic images are essential for prompt diagnosis and to minimize negative health outcomes in these patients. However, Salter–Harris I fracture in sickle cell patients can be very challenging due to these patients’ vulnerability to bone infections and sickle cell crisis. In this case report, our patient with a history of sickle cell disease and with a diagnosis of Salter–Harris I fracture was treated with surgical intervention as type V, which is discussed in this article, and responded well to treatment. Thus, this case suggests a new approach to managing Salter–Harris I fractures complicated with osteomyelitis in sickle cell patients.","PeriodicalId":74162,"journal":{"name":"Medicines (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48343816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Osteopathic Manipulative Treatment Decreases Hospital Stay and Healthcare Cost in the Neonatal Intensive Care Unit. 骨科手法治疗减少新生儿重症监护病房的住院时间和医疗保健费用
Pub Date : 2022-09-21 DOI: 10.3390/medicines9100049
Hannah Roland, Amanda Brown, Amy Rousselot, Natalie Freeman, J Michael Wieting, Stephen Bergman, Debasis Mondal

Osteopathic manipulative treatment (OMT) is used in both inpatient and outpatient settings. Evidence suggests that OMT can reduce both patients' recovery time and the financial cost of their acute medical treatment and rehabilitation. Multiple studies from neonatal intensive care units (NICUs) are presented in this article that demonstrate infants treated with OMT recover faster, are discharged earlier, and have lower healthcare costs than their non-OMT-treated counterparts. Data clearly show that adjunctive OMT facilitates feeding coordination in newborns, such as latching, suckling, swallowing, and breathing, and increases long-term weight gain and maintenance, which reduces hospital length of stay (LOS). Osteopathic techniques, such as soft tissue manipulation, balanced ligamentous tension, myofascial release, and osteopathic cranial manipulation (OCM), can reduce regurgitation, vomiting, milky bilious, or bloody discharge and decrease the need for constipation treatment. OMT can also be effective in reducing the complications of pneumonia in premature babies. Studies show the use of OCM and lymphatic pump technique (LPT) reduces the occurrence of both aspiration and environmentally acquired pneumonia, resulting in significantly lower morbidity and mortality in infants. Based on published findings, it is determined that OMT is clinically effective, cost efficient, a less invasive alternative to surgery, and a less toxic choice to pharmacologic drugs. Therefore, routine incorporation of OMT in the NICU can be of great benefit in infants with multiple disorders. Future OMT research should aim to initiate clinical trial designs that include randomized controlled trials with larger cohorts of infants admitted to the NICU. Furthermore, a streamlined and concerted effort to elucidate the underlying molecular mechanisms associated with the beneficial effects of OMT will aid in understanding the significant value of incorporating OMT into optimal patient care.

整骨疗法手法治疗(OMT)用于住院和门诊设置。有证据表明,OMT可以减少患者的恢复时间和他们的急性医疗和康复的经济成本。本文介绍了来自新生儿重症监护病房(NICUs)的多项研究,这些研究表明,接受OMT治疗的婴儿比未接受OMT治疗的婴儿恢复得更快,出院时间更早,医疗费用更低。数据清楚地表明,辅助OMT有助于新生儿的喂养协调,如锁住、哺乳、吞咽和呼吸,并增加长期体重增加和维持,从而缩短住院时间(LOS)。整骨疗法技术,如软组织操作、平衡韧带张力、肌筋膜释放和整骨颅操作(OCM),可以减少反流、呕吐、乳白色胆汁或血性排出,减少便秘治疗的需要。OMT也可以有效地减少早产儿肺炎的并发症。研究表明,OCM和淋巴泵技术(LPT)的使用减少了吸入性和环境获得性肺炎的发生,显著降低了婴儿的发病率和死亡率。根据已发表的研究结果,确定OMT在临床上是有效的,成本效益高,是手术的一种侵入性较小的替代方法,并且是药物药物毒性较小的选择。因此,在新生儿重症监护室常规纳入OMT对患有多种疾病的婴儿有很大的好处。未来的OMT研究应旨在启动临床试验设计,包括随机对照试验,纳入更多的新生儿重症监护病房。此外,通过精简和协调的努力,阐明与OMT有益作用相关的潜在分子机制,将有助于理解将OMT纳入最佳患者护理的重要价值。
{"title":"Osteopathic Manipulative Treatment Decreases Hospital Stay and Healthcare Cost in the Neonatal Intensive Care Unit.","authors":"Hannah Roland, Amanda Brown, Amy Rousselot, Natalie Freeman, J Michael Wieting, Stephen Bergman, Debasis Mondal","doi":"10.3390/medicines9100049","DOIUrl":"10.3390/medicines9100049","url":null,"abstract":"<p><p>Osteopathic manipulative treatment (OMT) is used in both inpatient and outpatient settings. Evidence suggests that OMT can reduce both patients' recovery time and the financial cost of their acute medical treatment and rehabilitation. Multiple studies from neonatal intensive care units (NICUs) are presented in this article that demonstrate infants treated with OMT recover faster, are discharged earlier, and have lower healthcare costs than their non-OMT-treated counterparts. Data clearly show that adjunctive OMT facilitates feeding coordination in newborns, such as latching, suckling, swallowing, and breathing, and increases long-term weight gain and maintenance, which reduces hospital length of stay (LOS). Osteopathic techniques, such as soft tissue manipulation, balanced ligamentous tension, myofascial release, and osteopathic cranial manipulation (OCM), can reduce regurgitation, vomiting, milky bilious, or bloody discharge and decrease the need for constipation treatment. OMT can also be effective in reducing the complications of pneumonia in premature babies. Studies show the use of OCM and lymphatic pump technique (LPT) reduces the occurrence of both aspiration and environmentally acquired pneumonia, resulting in significantly lower morbidity and mortality in infants. Based on published findings, it is determined that OMT is clinically effective, cost efficient, a less invasive alternative to surgery, and a less toxic choice to pharmacologic drugs. Therefore, routine incorporation of OMT in the NICU can be of great benefit in infants with multiple disorders. Future OMT research should aim to initiate clinical trial designs that include randomized controlled trials with larger cohorts of infants admitted to the NICU. Furthermore, a streamlined and concerted effort to elucidate the underlying molecular mechanisms associated with the beneficial effects of OMT will aid in understanding the significant value of incorporating OMT into optimal patient care.</p>","PeriodicalId":74162,"journal":{"name":"Medicines (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607199/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48153448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Frailty Status with Risk of Fall among Hospitalized Elderly Patients: A Cross-Sectional Study in an Acute Geriatric Unit. 住院老年患者虚弱状态与跌倒风险的关联:急性老年病房的横断面研究
Pub Date : 2022-09-20 DOI: 10.3390/medicines9100048
Abrar-Ahmad Zulfiqar, Perla Habchi, Ibrahima Amadou Dembele, Emmanuel Andres

Introduction: The objective was to study the association of frailty status in hospitalized elderly patients with risk of fall in an acute geriatric unit and to characterize elderly “fallers” using a comprehensive gerontological assessment. Patients and Methods: A cross-sectional study was conducted in patients over 65 years of age and hospitalized in an acute geriatric unit. This work was carried out in the Acute Geriatric Medicine Unit, Saint-Julien Hospital, Center Hospitalier Universitaire de Rouen from 1 June 2016 to 15 August 2016. Results: 172 patients were included during the collection period, with a female predominance of 115 patients (66.9%). The average age of the sample was 79.37 years old (65−85). The average CHARLSON score was 6.93 (3−16). Patients came from home in 81.4% of cases (i.e., 140 patients), and from a nursing home in 18.6% of cases (i.e., 32 patients). The risk of falling, as assessed by the Monopodal Support Test, returned as abnormal for 127 patients. In our series, there was a statistically strong link between the risk of falling and the presence of a dementia pathology (p = 0.009), the presence of a vitamin D deficiency (p = 0.03), the presence of frailty, as assessed by the three scales (modified SEGA scale, Fried scale and CFS/7 (<0.001), a high comorbidity score (p = 0.04), and a disturbed autonomy assessment according to IADL (p = 1.02 × 10−5) and according to ADL (p = 6.4 × 10−8). There was a statistically strong link between the risk of falling and the occurrence of death (p = 0.01). Conclusion: The consequences of the fall in terms of morbidity and mortality and the frequency of this event with advancing age and its impact on the quality of life as well as on health expenditure justify a systematic identification of the risk of falling in the elderly population. It is therefore important to have sensitive, specific, and reproducible tools available for identifying elderly people at high risk of falling.

前言:目的是研究急性老年病房住院老年患者虚弱状态与跌倒风险的关系,并利用综合老年学评估来描述老年“跌倒者”的特征。患者和方法:一项横断面研究在65岁以上急性老年病房住院的患者中进行。这项工作于2016年6月1日至2016年8月15日在鲁昂大学医院中心圣朱利安医院急性老年医学科进行。结果:收集期间共纳入172例患者,其中女性占115例(66.9%)。样本平均年龄为79.37岁(65 ~ 85岁)。CHARLSON平均评分为6.93分(3−16分)。81.4%的患者来自家庭(即140名患者),18.6%的患者来自养老院(即32名患者)。经单足支撑试验评估,127例患者的跌倒风险恢复为异常。在我们的研究中,通过三种量表(改良SEGA量表、Fried量表和CFS/7量表)评估,跌倒风险与痴呆病理(p = 0.009)、维生素D缺乏(p = 0.03)、虚弱(p = 0.03)之间存在统计学上的强烈联系。
{"title":"Association of Frailty Status with Risk of Fall among Hospitalized Elderly Patients: A Cross-Sectional Study in an Acute Geriatric Unit.","authors":"Abrar-Ahmad Zulfiqar,&nbsp;Perla Habchi,&nbsp;Ibrahima Amadou Dembele,&nbsp;Emmanuel Andres","doi":"10.3390/medicines9100048","DOIUrl":"https://doi.org/10.3390/medicines9100048","url":null,"abstract":"<p><p>Introduction: The objective was to study the association of frailty status in hospitalized elderly patients with risk of fall in an acute geriatric unit and to characterize elderly “fallers” using a comprehensive gerontological assessment. Patients and Methods: A cross-sectional study was conducted in patients over 65 years of age and hospitalized in an acute geriatric unit. This work was carried out in the Acute Geriatric Medicine Unit, Saint-Julien Hospital, Center Hospitalier Universitaire de Rouen from 1 June 2016 to 15 August 2016. Results: 172 patients were included during the collection period, with a female predominance of 115 patients (66.9%). The average age of the sample was 79.37 years old (65−85). The average CHARLSON score was 6.93 (3−16). Patients came from home in 81.4% of cases (i.e., 140 patients), and from a nursing home in 18.6% of cases (i.e., 32 patients). The risk of falling, as assessed by the Monopodal Support Test, returned as abnormal for 127 patients. In our series, there was a statistically strong link between the risk of falling and the presence of a dementia pathology (p = 0.009), the presence of a vitamin D deficiency (p = 0.03), the presence of frailty, as assessed by the three scales (modified SEGA scale, Fried scale and CFS/7 (<0.001), a high comorbidity score (p = 0.04), and a disturbed autonomy assessment according to IADL (p = 1.02 × 10−5) and according to ADL (p = 6.4 × 10−8). There was a statistically strong link between the risk of falling and the occurrence of death (p = 0.01). Conclusion: The consequences of the fall in terms of morbidity and mortality and the frequency of this event with advancing age and its impact on the quality of life as well as on health expenditure justify a systematic identification of the risk of falling in the elderly population. It is therefore important to have sensitive, specific, and reproducible tools available for identifying elderly people at high risk of falling.</p>","PeriodicalId":74162,"journal":{"name":"Medicines (Basel, Switzerland)","volume":"9 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609654/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10872900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effectiveness of GLP-1 Receptor Agonist Semaglutide on Body Composition in Elderly Obese Diabetic Patients: A Pilot Study. GLP-1受体激动剂西马鲁肽对老年肥胖糖尿病患者体成分的影响:一项初步研究
Pub Date : 2022-09-16 DOI: 10.3390/medicines9090047
Yoshinori Ozeki, Takayuki Masaki, Akari Kamata, Shotaro Miyamoto, Yuichi Yoshida, Mitsuhiro Okamoto, Koro Gotoh, Hirotaka Shibata

Background and objectives: This study aimed to investigate the changes in obesity severity, glucose metabolism, and body composition in patients with obesity and type 2 diabetes mellitus treated with glucagon-like peptide 1 receptor agonist (GLP1-RA) semaglutide.

Materials and methods: Body weight (BW), metabolic parameters, and body composition were examined before and 3 months after semaglutide administration. The mass of body fat (FM), fat weight percentage (%FM), mass of skeletal muscle (MM), skeletal MM percentage (%MM), and limb muscles were measured using the bioelectrical impedance method.

Results: Semaglutide dramatically reduced the weight, the body mass index (BMI), and the levels of the glucose metabolic markers, including fasting blood glucose and hemoglobin A1c, and accelerated the loss of excess BW. FM, MM, and %FM after semaglutide treatment also decreased. Conversely, semaglutide had no effect on the %MM after 3 months. In limb muscle analyses, right upper and lower leg muscle percentages, left upper and lower leg muscles, and the ratios of the lower/upper muscles were maintained by semaglutide treatment.

Conclusions: These results suggest that the GLP1-RA semaglutide effectively reduces body adiposity while maintaining the MM in obese type 2 diabetic patients.

背景与目的:本研究旨在探讨胰高血糖素样肽1受体激动剂(GLP1-RA)半马鲁肽治疗肥胖合并2型糖尿病患者的肥胖严重程度、糖代谢和体成分的变化。材料与方法:在给药前和给药后3个月测定体重、代谢参数和体成分。采用生物电阻抗法测定体脂质量(FM)、脂肪重量百分比(%FM)、骨骼肌质量(MM)、骨骼肌百分比(%MM)和肢体肌肉。结果:Semaglutide显著降低体重、体重指数(BMI)和葡萄糖代谢指标水平,包括空腹血糖和血红蛋白A1c,并加速多余体重的损失。西马鲁肽治疗后FM、MM和%FM也有所下降。相反,semaglutide对3个月后的%MM没有影响。在肢体肌肉分析中,右上肢和下肢肌肉百分比,左上肢和下肢肌肉百分比,以及下肢/上肢肌肉比例通过semaglutide治疗保持不变。结论:这些结果表明GLP1-RA semaglutide可以有效降低肥胖2型糖尿病患者的体脂,同时维持其MM。
{"title":"The Effectiveness of GLP-1 Receptor Agonist Semaglutide on Body Composition in Elderly Obese Diabetic Patients: A Pilot Study.","authors":"Yoshinori Ozeki,&nbsp;Takayuki Masaki,&nbsp;Akari Kamata,&nbsp;Shotaro Miyamoto,&nbsp;Yuichi Yoshida,&nbsp;Mitsuhiro Okamoto,&nbsp;Koro Gotoh,&nbsp;Hirotaka Shibata","doi":"10.3390/medicines9090047","DOIUrl":"https://doi.org/10.3390/medicines9090047","url":null,"abstract":"<p><strong>Background and objectives: </strong>This study aimed to investigate the changes in obesity severity, glucose metabolism, and body composition in patients with obesity and type 2 diabetes mellitus treated with glucagon-like peptide 1 receptor agonist (GLP1-RA) semaglutide.</p><p><strong>Materials and methods: </strong>Body weight (BW), metabolic parameters, and body composition were examined before and 3 months after semaglutide administration. The mass of body fat (FM), fat weight percentage (%FM), mass of skeletal muscle (MM), skeletal MM percentage (%MM), and limb muscles were measured using the bioelectrical impedance method.</p><p><strong>Results: </strong>Semaglutide dramatically reduced the weight, the body mass index (BMI), and the levels of the glucose metabolic markers, including fasting blood glucose and hemoglobin A1c, and accelerated the loss of excess BW. FM, MM, and %FM after semaglutide treatment also decreased. Conversely, semaglutide had no effect on the %MM after 3 months. In limb muscle analyses, right upper and lower leg muscle percentages, left upper and lower leg muscles, and the ratios of the lower/upper muscles were maintained by semaglutide treatment.</p><p><strong>Conclusions: </strong>These results suggest that the GLP1-RA semaglutide effectively reduces body adiposity while maintaining the MM in obese type 2 diabetic patients.</p>","PeriodicalId":74162,"journal":{"name":"Medicines (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502467/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33469515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Chest X-ray Features in Drug-Resistant Tuberculosis Patients in Nigeria; a Retrospective Record Review. 尼日利亚耐药结核病患者的胸部x线特征回顾性记录评审。
Pub Date : 2022-09-06 DOI: 10.3390/medicines9090046
Olanrewaju Oladimeji, Adenike Temitope Adeniji-Sofoluwe, Yasir Othman, Victor Abiola Adepoju, Kelechi Elizabeth Oladimeji, Bamidele Paul Atiba, Felix Emeka Anyiam, Babatunde A Odugbemi, Tolulope Afolaranmi, Ayuba Ibrahim Zoakah

Chest X-ray (CXR) characteristics of patients with drug-resistant tuberculosis (DR-TB) depend on a variety of factors, and therefore, identifying the influence of these factors on the appearance of DR-TB in chest X-rays can help physicians improve diagnosis and clinical suspicion. Our aim was to describe the CXR presentation of patients with DR-TB and its association with clinical and demographic factors. A retrospective analysis of the CXRs of DR-TB patients in Nigeria between 2010 and 2016 was performed, reviewing features of chest radiographs, such as cavitation, opacity and effusion, infiltration and lung destruction. The association of these abnormal CXR findings with clinical and demographic characteristics was evaluated using bivariate and multivariate models, and a p-value < 0.05 was considered statistically significant with a 95% confidence interval. A total of 2555 DR-TB patients were studied, the majority (66.9%) were male, aged 29−38 years (36.8%), previously treated (77%), from the South West treatment zone (43.5%), HIV negative (76.7%) and bacteriologically diagnosed (89%). X-ray findings were abnormal in 97% of the participants, with cavitation being the most common (41.5%). Cavitation, effusion, fibrosis, and infiltration were higher in patients presenting in the South West zone and in those previously treated for DR-TB, while lung destruction was significantly higher in patients who are from the South South zone, and in those previously treated for DR-TB. Patients from the South East zone (AOR: 6.667, 95% CI: 1.383−32.138, p = 0.018), the North East zone (AOR: 6.667, 95% CI: 1.179−37.682, p = 0.032) and the North West zone (AOR: 6.30, 95% CI: 1.332−29.787, p = 0.020) had a significantly increased likelihood of abnormal chest X-ray findings, and prior TB treatment predisposed the patient to an increased likelihood of abnormal chest X-ray findings compared to new patients (AOR: 8.256, 95% CI: 3.718−18.330, p = 0.001). The finding of a significantly higher incidence of cavities, effusions and fibrosis in DR-TB patients previously treated could indicate late detection or presentation with advanced DR-TB disease, which may require a more individualized regimen or surgical intervention.

耐药结核病(DR-TB)患者的胸片特征取决于多种因素,因此,确定这些因素对耐药结核病胸片表现的影响可以帮助医生提高诊断和临床怀疑。我们的目的是描述耐药结核病患者的CXR表现及其与临床和人口因素的关系。回顾性分析了2010年至2016年尼日利亚耐药结核病患者的x线照片,回顾了胸片的特征,如空化、混浊和积液、浸润和肺破坏。使用双变量和多变量模型评估这些异常CXR结果与临床和人口学特征的相关性,p值< 0.05被认为具有统计学意义,置信区间为95%。共研究了2555例耐药结核病患者,多数(66.9%)为男性,年龄29 ~ 38岁(36.8%),既往治疗(77%),来自西南治疗区(43.5%),HIV阴性(76.7%),细菌学诊断(89%)。97%的参与者的x线表现异常,其中以空化最为常见(41.5%)。西南地区和以前接受过耐药结核病治疗的患者肺空化、积液、纤维化和浸润较高,而来自南南地区和以前接受过耐药结核病治疗的患者肺破坏明显较高。来自东南部地区(AOR: 6.667, 95% CI: 1.383 ~ 32.138, p = 0.018)、东北部地区(AOR: 6.667, 95% CI: 1.179 ~ 37.682, p = 0.032)和西北部地区(AOR: 6.30, 95% CI: 1.332 ~ 29.787, p = 0.020)的患者出现胸部x线异常的可能性显著增加,且与新患者相比,先前接受过结核病治疗的患者出现胸部x线异常的可能性增加(AOR: 8.256, 95% CI: 3.718 ~ 18.330, p = 0.001)。先前接受过治疗的耐药结核病患者出现腔洞、积液和纤维化的发生率明显较高,这可能表明发现较晚或表现为晚期耐药结核病,这可能需要更个性化的治疗方案或手术干预。
{"title":"Chest X-ray Features in Drug-Resistant Tuberculosis Patients in Nigeria; a Retrospective Record Review.","authors":"Olanrewaju Oladimeji,&nbsp;Adenike Temitope Adeniji-Sofoluwe,&nbsp;Yasir Othman,&nbsp;Victor Abiola Adepoju,&nbsp;Kelechi Elizabeth Oladimeji,&nbsp;Bamidele Paul Atiba,&nbsp;Felix Emeka Anyiam,&nbsp;Babatunde A Odugbemi,&nbsp;Tolulope Afolaranmi,&nbsp;Ayuba Ibrahim Zoakah","doi":"10.3390/medicines9090046","DOIUrl":"https://doi.org/10.3390/medicines9090046","url":null,"abstract":"<p><p>Chest X-ray (CXR) characteristics of patients with drug-resistant tuberculosis (DR-TB) depend on a variety of factors, and therefore, identifying the influence of these factors on the appearance of DR-TB in chest X-rays can help physicians improve diagnosis and clinical suspicion. Our aim was to describe the CXR presentation of patients with DR-TB and its association with clinical and demographic factors. A retrospective analysis of the CXRs of DR-TB patients in Nigeria between 2010 and 2016 was performed, reviewing features of chest radiographs, such as cavitation, opacity and effusion, infiltration and lung destruction. The association of these abnormal CXR findings with clinical and demographic characteristics was evaluated using bivariate and multivariate models, and a p-value < 0.05 was considered statistically significant with a 95% confidence interval. A total of 2555 DR-TB patients were studied, the majority (66.9%) were male, aged 29−38 years (36.8%), previously treated (77%), from the South West treatment zone (43.5%), HIV negative (76.7%) and bacteriologically diagnosed (89%). X-ray findings were abnormal in 97% of the participants, with cavitation being the most common (41.5%). Cavitation, effusion, fibrosis, and infiltration were higher in patients presenting in the South West zone and in those previously treated for DR-TB, while lung destruction was significantly higher in patients who are from the South South zone, and in those previously treated for DR-TB. Patients from the South East zone (AOR: 6.667, 95% CI: 1.383−32.138, p = 0.018), the North East zone (AOR: 6.667, 95% CI: 1.179−37.682, p = 0.032) and the North West zone (AOR: 6.30, 95% CI: 1.332−29.787, p = 0.020) had a significantly increased likelihood of abnormal chest X-ray findings, and prior TB treatment predisposed the patient to an increased likelihood of abnormal chest X-ray findings compared to new patients (AOR: 8.256, 95% CI: 3.718−18.330, p = 0.001). The finding of a significantly higher incidence of cavities, effusions and fibrosis in DR-TB patients previously treated could indicate late detection or presentation with advanced DR-TB disease, which may require a more individualized regimen or surgical intervention.</p>","PeriodicalId":74162,"journal":{"name":"Medicines (Basel, Switzerland)","volume":"9 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504772/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9077124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Cutting the First Turf to Heal Post-SSRI Sexual Dysfunction: A Male Retrospective Cohort Study. 治疗ssri后性功能障碍:一项男性回顾性队列研究。
Pub Date : 2022-09-01 DOI: 10.3390/medicines9090045
Rosaria De Luca, Mirjam Bonanno, Alfredo Manuli, Rocco Salvatore Calabrò

Post-SSRI sexual dysfunction (PSSD) is a set of heterogeneous sexual problems, which may arise during the administration of selective serotonin reuptake inhibitors (SSRIs) and persist after their discontinuation. PSSD is a rare clinical entity, and it is commonly associated with non-sexual concerns, including emotional and cognitive problems and poor quality of life. To date, however, no effective treatment is available. The aim of this study was to retrospectively evaluate the potential efficacy of the different treatments used in clinical practice in improving male PSSD. Of the 30 patients referred to our neurobehavioral outpatient clinic from January 2020 to December 2021, 13 Caucasian male patients (mean age 29.53 ± 4.57 years), previously treated with SSRIs, were included in the study. Patients with major depressive disorder and/or psychotic symptoms were excluded a priori to avoid overlapping symptomatology, and potentially reduce the misdiagnosis rate. To treat PSSD, we decided to use drugs positively affecting the brain dopamine/serotonin ratio, such as bupropion and vortioxetine, as well as other compounds. This latter drug is known not to cause or reverse iatrogenic SD. Most patients, after treatment with vortioxetine and/or nutraceuticals, reported a significant improvement in all International Index of Erectile Function-(IIEF-5) domains (p < 0.05) from baseline (T0) to 12-month follow-up (T1). Moreover, the only patient treated with pelvic muscle vibration reached very positive results. Although our data come from a retrospective open-label study with a small sample size, drugs positively modulating the central nervous system serotonin/dopamine ratio, such as vortioxetine, could be used to potentially improve PSSD. Large-sample prospective cohort studies and randomized clinical trials are needed to investigate the real prevalence of this clinical entity and confirm such a promising approach to a potentially debilitating illness.

ssri后性功能障碍(PSSD)是一组异质性性问题,可能在服用选择性血清素再摄取抑制剂(SSRIs)期间出现,并在停药后持续存在。PSSD是一种罕见的临床实体,它通常与非性问题有关,包括情绪和认知问题以及生活质量差。然而,到目前为止,还没有有效的治疗方法。本研究的目的是回顾性评价临床实践中使用的不同治疗方法在改善男性PSSD方面的潜在疗效。在2020年1月至2021年12月至我们神经行为门诊就诊的30例患者中,13例既往接受过SSRIs治疗的高加索男性患者(平均年龄29.53±4.57岁)被纳入研究。排除有重性抑郁障碍和/或精神病症状的患者,以避免症状重叠,并有可能降低误诊率。为了治疗PSSD,我们决定使用积极影响大脑多巴胺/血清素比率的药物,如安非他酮和沃替西汀,以及其他化合物。已知后一种药物不会引起或逆转医源性SD。大多数患者在接受沃替西汀和/或营养品治疗后,从基线(T0)到12个月随访(T1),所有国际勃起功能指数-(IIEF-5)域均有显著改善(p < 0.05)。此外,唯一接受盆腔肌肉振动治疗的患者取得了非常积极的结果。虽然我们的数据来自一个小样本的回顾性开放标签研究,但正向调节中枢神经系统血清素/多巴胺比率的药物,如vortioxetine,可能用于潜在地改善PSSD。需要大样本前瞻性队列研究和随机临床试验来调查这种临床实体的真实患病率,并确认这种有希望的方法治疗潜在的衰弱性疾病。
{"title":"Cutting the First Turf to Heal Post-SSRI Sexual Dysfunction: A Male Retrospective Cohort Study.","authors":"Rosaria De Luca,&nbsp;Mirjam Bonanno,&nbsp;Alfredo Manuli,&nbsp;Rocco Salvatore Calabrò","doi":"10.3390/medicines9090045","DOIUrl":"https://doi.org/10.3390/medicines9090045","url":null,"abstract":"<p><p>Post-SSRI sexual dysfunction (PSSD) is a set of heterogeneous sexual problems, which may arise during the administration of selective serotonin reuptake inhibitors (SSRIs) and persist after their discontinuation. PSSD is a rare clinical entity, and it is commonly associated with non-sexual concerns, including emotional and cognitive problems and poor quality of life. To date, however, no effective treatment is available. The aim of this study was to retrospectively evaluate the potential efficacy of the different treatments used in clinical practice in improving male PSSD. Of the 30 patients referred to our neurobehavioral outpatient clinic from January 2020 to December 2021, 13 Caucasian male patients (mean age 29.53 ± 4.57 years), previously treated with SSRIs, were included in the study. Patients with major depressive disorder and/or psychotic symptoms were excluded a priori to avoid overlapping symptomatology, and potentially reduce the misdiagnosis rate. To treat PSSD, we decided to use drugs positively affecting the brain dopamine/serotonin ratio, such as bupropion and vortioxetine, as well as other compounds. This latter drug is known not to cause or reverse iatrogenic SD. Most patients, after treatment with vortioxetine and/or nutraceuticals, reported a significant improvement in all International Index of Erectile Function-(IIEF-5) domains (p < 0.05) from baseline (T0) to 12-month follow-up (T1). Moreover, the only patient treated with pelvic muscle vibration reached very positive results. Although our data come from a retrospective open-label study with a small sample size, drugs positively modulating the central nervous system serotonin/dopamine ratio, such as vortioxetine, could be used to potentially improve PSSD. Large-sample prospective cohort studies and randomized clinical trials are needed to investigate the real prevalence of this clinical entity and confirm such a promising approach to a potentially debilitating illness.</p>","PeriodicalId":74162,"journal":{"name":"Medicines (Basel, Switzerland)","volume":"9 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503765/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9077123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Ashi Scalp Acupuncture in the Treatment of Secondary Trigeminal Neuralgia Induced by Multiple Sclerosis: A Case Report. 阿石头皮针刺治疗多发性硬化症致继发性三叉神经痛1例。
Pub Date : 2022-08-12 DOI: 10.3390/medicines9080044
Qiong Schürer, Hamdy Shaban, Andreas R Gantenbein, Giada Todeschini, Saroj K Pradhan

Background: Multiple sclerosis (MS) is an autoimmune, chronic, inflammatory, demyelinating, and axonal degeneration disease of the central nervous system. Trigeminal neuralgia (TN), a neuropathic facial paroxysmal pain, is prevalent among MS patients. Because of the inadequacy of the comprehension of MS-related TN pathophysiological mechanisms, TN remains arduous in its treatment approaches. Acupuncture as a non-pharmacological therapy could be a promising complementary therapy for the treatment of TN. MS gradual neural damage might affect the muscles' function. This can lead to acute or paroxysmal pain in the form of spasms that might progress to formation of myofascial trigger points also known in traditional Chinese medicine as Ashi points (AP). Localising these AP through palpation and pain sensation feedback in patients with MS is an indicator of disease progression. Pathologically, these points reveal the disharmony of soft tissue and internal organs. Methods: This case report examined the pain relief outcome with Ashi scalp acupuncture (ASA) in a secondary TN patient who was unsuccessfully treated multiple times with body acupuncture. The main outline measure was to quantify pain intensity using a numerical rating scale (NRS) before and after each acupuncture therapy. The patient was treated on the scalp for a total of eight times, twice a week over four weeks. Results: A reduction in secondary TN pain intensity was observed after each session. On average, the patient expressed severe pain (NRS: 8.0 ± 2.20) before ASA treatment, which significantly decreased after therapy to mild pain (NRS: 2.0 ± 1.64). Conclusions: Significant improvements in pain intensity reduction after each acupuncture treatment without any adverse effects were observed.

背景:多发性硬化症(MS)是一种自身免疫性、慢性、炎症性、脱髓鞘和中枢神经系统轴突变性疾病。三叉神经痛(TN)是一种神经性面部阵发性疼痛,在多发性硬化症患者中很普遍。由于对ms相关的TN病理生理机制的认识不足,TN的治疗方法仍然艰巨。针刺作为一种非药物治疗方法,可能是治疗多发性硬化症的一种很有前途的辅助治疗方法。这可能导致痉挛形式的急性或阵发性疼痛,这种疼痛可能发展为肌筋膜触发点的形成,在传统中医中也称为阿氏点(AP)。在MS患者中,通过触诊和疼痛感觉反馈定位这些AP是疾病进展的一个指标。病理上,这些穴位显示了软组织和内脏的不协调。方法:本病例报告分析了多次体针治疗无效的继发性TN患者,用阿什头皮针(ASA)缓解疼痛的结果。主要的大纲测量是在每次针灸治疗前后使用数值评定量表(NRS)量化疼痛强度。患者头皮治疗共8次,每周2次,持续4周。结果:每次疗程后观察到继发性TN疼痛强度的降低。ASA治疗前患者平均表现为重度疼痛(NRS: 8.0±2.20),治疗后患者平均表现为轻度疼痛(NRS: 2.0±1.64)。结论:每次针刺治疗后疼痛强度均有明显改善,且无不良反应。
{"title":"Ashi Scalp Acupuncture in the Treatment of Secondary Trigeminal Neuralgia Induced by Multiple Sclerosis: A Case Report.","authors":"Qiong Schürer,&nbsp;Hamdy Shaban,&nbsp;Andreas R Gantenbein,&nbsp;Giada Todeschini,&nbsp;Saroj K Pradhan","doi":"10.3390/medicines9080044","DOIUrl":"https://doi.org/10.3390/medicines9080044","url":null,"abstract":"<p><p><b>Background</b>: Multiple sclerosis (MS) is an autoimmune, chronic, inflammatory, demyelinating, and axonal degeneration disease of the central nervous system. Trigeminal neuralgia (TN), a neuropathic facial paroxysmal pain, is prevalent among MS patients. Because of the inadequacy of the comprehension of MS-related TN pathophysiological mechanisms, TN remains arduous in its treatment approaches. Acupuncture as a non-pharmacological therapy could be a promising complementary therapy for the treatment of TN. MS gradual neural damage might affect the muscles' function. This can lead to acute or paroxysmal pain in the form of spasms that might progress to formation of myofascial trigger points also known in traditional Chinese medicine as Ashi points (AP). Localising these AP through palpation and pain sensation feedback in patients with MS is an indicator of disease progression. Pathologically, these points reveal the disharmony of soft tissue and internal organs. Methods: This case report examined the pain relief outcome with Ashi scalp acupuncture (ASA) in a secondary TN patient who was unsuccessfully treated multiple times with body acupuncture. The main outline measure was to quantify pain intensity using a numerical rating scale (NRS) before and after each acupuncture therapy. The patient was treated on the scalp for a total of eight times, twice a week over four weeks. <b>Results</b>: A reduction in secondary TN pain intensity was observed after each session. On average, the patient expressed severe pain (NRS: 8.0 ± 2.20) before ASA treatment, which significantly decreased after therapy to mild pain (NRS: 2.0 ± 1.64). <b>Conclusions</b>: Significant improvements in pain intensity reduction after each acupuncture treatment without any adverse effects were observed.</p>","PeriodicalId":74162,"journal":{"name":"Medicines (Basel, Switzerland)","volume":"9 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414573/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40415103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review. 与基于 mRNA 的 COVID-19 疫苗相关的罕见异质性不良事件:系统综述。
Pub Date : 2022-08-11 DOI: 10.3390/medicines9080043
Rana I Oueijan, Olivia R Hill, Peter D Ahiawodzi, Pius S Fasinu, Dorothea K Thompson

Background: Since the successful development, approval, and administration of vaccines against SARS-CoV-2, the causative agent of COVID-19, there have been reports in the published literature, passive surveillance systems, and other pharmacovigilance platforms of a broad spectrum of adverse events following COVID-19 vaccination. A comprehensive review of the more serious adverse events associated with the Pfizer-BioNTech and Moderna mRNA vaccines is warranted, given the massive number of vaccine doses administered worldwide and the novel mechanism of action of these mRNA vaccines in the healthcare industry. Methods: A systematic review of the literature was conducted to identify relevant studies that have reported mRNA COVID-19 vaccine-related adverse events. Results: Serious and severe adverse events following mRNA COVID-19 vaccinations are rare. While a definitive causal relationship was not established in most cases, important adverse events associated with post-vaccination included rare and non-fatal myocarditis and pericarditis in younger vaccine recipients, thrombocytopenia, neurological effects such as seizures and orofacial events, skin reactions, and allergic hypersensitivities. Conclusions: As a relatively new set of vaccines already administered to billions of people, COVID-19 mRNA-based vaccines are generally safe and efficacious. Further studies on long-term adverse events and other unpredictable reactions in close proximity to mRNA vaccination are required.

背景:自成功开发、批准和接种针对 COVID-19 致病菌 SARS-CoV-2 的疫苗以来,已发表的文献、被动监测系统和其他药物警戒平台中都有关于接种 COVID-19 疫苗后发生各种不良事件的报道。鉴于辉瑞生物技术公司和 Moderna mRNA 疫苗在全球范围内的接种剂量巨大,而且这些 mRNA 疫苗在医疗保健行业的作用机制新颖,因此有必要对与辉瑞生物技术公司和 Moderna mRNA 疫苗相关的较严重不良事件进行全面审查。研究方法对文献进行系统回顾,以确定报道过 mRNA COVID-19 疫苗相关不良事件的相关研究。结果接种 mRNA COVID-19 疫苗后发生严重和严重不良事件的情况很少见。虽然大多数情况下无法确定明确的因果关系,但与接种后相关的重要不良事件包括年轻疫苗接种者罕见的非致命性心肌炎和心包炎、血小板减少症、神经系统影响(如癫痫发作和口面部事件)、皮肤反应和过敏性过敏。结论:作为一种相对较新的疫苗,COVID-19 mRNA 疫苗已为数十亿人接种,总体上安全有效。需要进一步研究接种 mRNA 疫苗后的长期不良反应和其他不可预测的反应。
{"title":"Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review.","authors":"Rana I Oueijan, Olivia R Hill, Peter D Ahiawodzi, Pius S Fasinu, Dorothea K Thompson","doi":"10.3390/medicines9080043","DOIUrl":"10.3390/medicines9080043","url":null,"abstract":"<p><p><b>Background:</b> Since the successful development, approval, and administration of vaccines against SARS-CoV-2, the causative agent of COVID-19, there have been reports in the published literature, passive surveillance systems, and other pharmacovigilance platforms of a broad spectrum of adverse events following COVID-19 vaccination. A comprehensive review of the more serious adverse events associated with the Pfizer-BioNTech and Moderna mRNA vaccines is warranted, given the massive number of vaccine doses administered worldwide and the novel mechanism of action of these mRNA vaccines in the healthcare industry. <b>Methods:</b> A systematic review of the literature was conducted to identify relevant studies that have reported mRNA COVID-19 vaccine-related adverse events. <b>Results:</b> Serious and severe adverse events following mRNA COVID-19 vaccinations are rare. While a definitive causal relationship was not established in most cases, important adverse events associated with post-vaccination included rare and non-fatal myocarditis and pericarditis in younger vaccine recipients, thrombocytopenia, neurological effects such as seizures and orofacial events, skin reactions, and allergic hypersensitivities. <b>Conclusions:</b> As a relatively new set of vaccines already administered to billions of people, COVID-19 mRNA-based vaccines are generally safe and efficacious. Further studies on long-term adverse events and other unpredictable reactions in close proximity to mRNA vaccination are required.</p>","PeriodicalId":74162,"journal":{"name":"Medicines (Basel, Switzerland)","volume":"9 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416135/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40415102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medicines (Basel, Switzerland)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1